Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial-Reference-Cited by-同舟云学术

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial

Published:2013-06 Issue:7 Volume:14 Page:627-637
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Crosby Thomas,Hurt Christopher N,Falk Stephen,Gollins Simon,Mukherjee Somnath,Staffurth John,Ray Ruby,Bashir Nadim,Bridgewater John A,Geh J Ian,Cunningham David,Blazeby Jane,Roy Rajarshi,Maughan Tim,Griffiths Gareth

Publisher

Elsevier BV

Subject

Oncology

Reference40 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial;Lancet,2002

3. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial;Ychou;J Clin Oncol,2011

4. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma;Blazeby;Cancer,2000

5. Chemotherapy of locally advanced esophageal cancer: long term follow-up of a prospective randomized trial (RTOG 85-01);Cooper;JAMA,1999

Cited by 335 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery;Quality of Life Research;2024-07-27

2. Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 Trial;Journal of Clinical Oncology;2024-07-10

3. Advances in diagnosis and management of cancer of the esophagus;BMJ;2024-06-03

4. A systematic review of circulating predictive and prognostic biomarkers to aid the personalised use of radiotherapy in the radical treatment of patients with oesophageal cancer;Radiotherapy and Oncology;2024-06

5. S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus;Zeitschrift für Gastroenterologie;2024-04